Franklin Resources Inc. Purchases Shares of 500,000 Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Franklin Resources Inc. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 500,000 shares of the company's stock, valued at approximately $8,575,000. Franklin Resources Inc. owned approximately 0.79% of Guardian Pharmacy Services as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of GRDN. Wellington Management Group LLP purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $8,400,000. Allspring Global Investments Holdings LLC bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at $5,460,000. Maven Securities LTD bought a new stake in Guardian Pharmacy Services during the 3rd quarter valued at about $3,033,000. Seven Grand Managers LLC purchased a new position in Guardian Pharmacy Services in the 3rd quarter worth approximately $2,515,000. Finally, Foundry Partners LLC purchased a new position in shares of Guardian Pharmacy Services in the third quarter worth $1,680,000.

Insider Activity at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler purchased 7,000 shares of the firm's stock in a transaction dated Tuesday, November 19th. The shares were purchased at an average cost of $21.22 per share, with a total value of $148,540.00. Following the completion of the purchase, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the business's stock in a transaction that occurred on Friday, September 27th. The stock was bought at an average cost of $14.00 per share, with a total value of $499,996.00. Following the acquisition, the director now owns 35,714 shares of the company's stock, valued at approximately $499,996. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN traded down $0.43 during mid-day trading on Friday, reaching $21.41. 1,864,109 shares of the company were exchanged, compared to its average volume of 191,270. The business has a 50-day simple moving average of $21.19. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $25.74.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million for the quarter, compared to the consensus estimate of $303.21 million. As a group, equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of research reports. Truist Financial raised their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 target price on the stock. Finally, Raymond James assumed coverage on shares of Guardian Pharmacy Services in a research report on Monday, October 21st. They set an "outperform" rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.